» Articles » PMID: 6977009

Mechanisms of Syngeneic Tumor Rejection. Susceptibility of Host-selected Progressor Variants to Various Immunological Effector Cells

Overview
Journal J Exp Med
Date 1982 Feb 1
PMID 6977009
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The ultraviolet radiation-induced fibrosarcoma 1591 generally is rejected by normal syngeneic mice and only rarely exhibits progressive growth. We isolated five of these rare progressor tumors from normal animals to determine the selective pressures that had been exerted upon the parental tumor by normal immunocompetent hosts. We found that the variant tumor cell lines could neither induce nor be killed by tumor-specific lymphocytes, suggesting that selection had been exerted against tumor cells expressing the tumor-specific antigen. In contrast, no selection against natural killer cell activity or against nonspecific T cell-mediated immunity seems to have occurred because progressor tumor cells were highly sensitive to these types of effector cells and in fact induced these effector cells more effectively than did the parental tumor. Nude mice were found to be as capable as normal mice in generating natural killer activity in response to a challenge with progressor tumor cells, but they were unable to mount a nonspecific T lymphocyte response. This may account for the fact that the progressor tumors grew at a significantly faster rate in nude animals than in normal mice. Thus, our study shows that in this tumor system nonspecific T cell-mediated immunity may play a role in retarding tumor growth, but the absolute resistance of normal animals to progressive tumor growth critically depends upon the presence of T cell-mediated tumor-specific immunity. Furthermore, neither NK cells nor nonspecific cytotoxic T lymphocytes appear to play a role in immunoselection against this tumor in normal immunocompetent hosts.

Citing Articles

IFN-γ Critically Enables the Intratumoural Infiltration of CXCR3 CD8 T Cells to Drive Squamous Cell Carcinoma Regression.

Zeng Z, Veitch M, Kelly G, Tuong Z, Cruz J, Frazer I Cancers (Basel). 2021; 13(9).

PMID: 33925140 PMC: 8124943. DOI: 10.3390/cancers13092131.


CD8 T-cell-Mediated Immunoediting Influences Genomic Evolution and Immune Evasion in Murine Gliomas.

Kane J, Zhao J, Tsujiuchi T, Laffleur B, Arrieta V, Mahajan A Clin Cancer Res. 2020; 26(16):4390-4401.

PMID: 32430477 PMC: 7442699. DOI: 10.1158/1078-0432.CCR-19-3104.


IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner.

Liu R, Engels B, Schreiber K, Ciszewski C, Schietinger A, Schreiber H Proc Natl Acad Sci U S A. 2013; 110(20):8158-63.

PMID: 23637340 PMC: 3657809. DOI: 10.1073/pnas.1301022110.


Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes.

Wu T, Schreiber K, Arina A, Khodarev N, Efimova E, Rowley D Cancer Immun. 2011; 11:2.

PMID: 21714479 PMC: 3127375.


Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat.

Jean W, Spellman S, Wallenfriedman M, Flores C, Kurtz B, Hall W J Neurooncol. 2004; 66(1-2):39-49.

PMID: 15015768 DOI: 10.1023/b:neon.0000013477.94568.0f.


References
1.
Hibbs Jr J, Lambert Jr L, Remington J . Control of carcinogenesis: a possible role for the activated macrophage. Science. 1972; 177(4053):998-1000. DOI: 10.1126/science.177.4053.998. View

2.
Herberman R, Nunn M, LAVRIN D . Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer. 1975; 16(2):216-29. DOI: 10.1002/ijc.2910160204. View

3.
Fialkow P . Clonal origin of human tumors. Biochim Biophys Acta. 1976; 458(3):283-321. DOI: 10.1016/0304-419x(76)90003-2. View

4.
Kiessling R, Klein E, Wigzell H . "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 1975; 5(2):112-7. DOI: 10.1002/eji.1830050208. View

5.
Shustik C, Cohen I, Schwartz R, Waksal S . T lymphocytes with promiscuous cytotoxicity. Nature. 1976; 263(5579):699-701. DOI: 10.1038/263699a0. View